![Frontiers | The Molecular Mechanism of Transforming Growth Factor-β Signaling for Intestinal Fibrosis: A Mini-Review Frontiers | The Molecular Mechanism of Transforming Growth Factor-β Signaling for Intestinal Fibrosis: A Mini-Review](https://www.frontiersin.org/files/MyHome%20Article%20Library/435936/435936_Thumb_400.jpg)
Frontiers | The Molecular Mechanism of Transforming Growth Factor-β Signaling for Intestinal Fibrosis: A Mini-Review
![Frontiers | Role of Transforming Growth Factor-β1 in Regulating Fetal-Maternal Immune Tolerance in Normal and Pathological Pregnancy Frontiers | Role of Transforming Growth Factor-β1 in Regulating Fetal-Maternal Immune Tolerance in Normal and Pathological Pregnancy](https://www.frontiersin.org/files/Articles/689181/fimmu-12-689181-HTML/image_m/fimmu-12-689181-g001.jpg)
Frontiers | Role of Transforming Growth Factor-β1 in Regulating Fetal-Maternal Immune Tolerance in Normal and Pathological Pregnancy
![IJMS | Free Full-Text | Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment IJMS | Free Full-Text | Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment](https://www.mdpi.com/ijms/ijms-20-05822/article_deploy/html/images/ijms-20-05822-g001.png)
IJMS | Free Full-Text | Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment
![Surface topography is a context-dependent activator of TGF-β signaling in mesenchymal stem cells | bioRxiv Surface topography is a context-dependent activator of TGF-β signaling in mesenchymal stem cells | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/01/13/2020.01.13.903195/F3.large.jpg)
Surface topography is a context-dependent activator of TGF-β signaling in mesenchymal stem cells | bioRxiv
![Novel therapies emerging in oncology to target the TGF-β pathway | Journal of Hematology & Oncology | Full Text Novel therapies emerging in oncology to target the TGF-β pathway | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-021-01053-x/MediaObjects/13045_2021_1053_Fig2_HTML.png)
Novel therapies emerging in oncology to target the TGF-β pathway | Journal of Hematology & Oncology | Full Text
![Cells | Free Full-Text | TGF-β Regulates Collagen Type I Expression in Myoblasts and Myotubes via Transient Ctgf and Fgf-2 Expression Cells | Free Full-Text | TGF-β Regulates Collagen Type I Expression in Myoblasts and Myotubes via Transient Ctgf and Fgf-2 Expression](https://pub.mdpi-res.com/cells/cells-09-00375/article_deploy/html/images/cells-09-00375-g007.png?1583480874)
Cells | Free Full-Text | TGF-β Regulates Collagen Type I Expression in Myoblasts and Myotubes via Transient Ctgf and Fgf-2 Expression
![Transcriptional cofactors Ski and SnoN are major regulators of the TGF-β/Smad signaling pathway in health and disease | Signal Transduction and Targeted Therapy Transcriptional cofactors Ski and SnoN are major regulators of the TGF-β/Smad signaling pathway in health and disease | Signal Transduction and Targeted Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-018-0015-8/MediaObjects/41392_2018_15_Fig1_HTML.jpg)
Transcriptional cofactors Ski and SnoN are major regulators of the TGF-β/Smad signaling pathway in health and disease | Signal Transduction and Targeted Therapy
![Novel therapies emerging in oncology to target the TGF-β pathway | Journal of Hematology & Oncology | Full Text Novel therapies emerging in oncology to target the TGF-β pathway | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-021-01053-x/MediaObjects/13045_2021_1053_Fig1_HTML.png)
Novel therapies emerging in oncology to target the TGF-β pathway | Journal of Hematology & Oncology | Full Text
![TGF-β reduces DNA ds-break repair mechanisms to heighten genetic diversity and adaptability of CD44+/CD24− cancer cells | eLife TGF-β reduces DNA ds-break repair mechanisms to heighten genetic diversity and adaptability of CD44+/CD24− cancer cells | eLife](https://iiif.elifesciences.org/lax/21615%2Felife-21615-resp-fig1-v2.tif/full/full/0/default.jpg)
TGF-β reduces DNA ds-break repair mechanisms to heighten genetic diversity and adaptability of CD44+/CD24− cancer cells | eLife
![Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells | Protocol Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells | Protocol](https://cloudfront.jove.com/files/ftp_upload/61830/61830fig01.jpg)
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells | Protocol
![TGF-β uses a novel mode of receptor activation to phosphorylate SMAD1/5 and induce epithelial-to-mesenchymal transition | eLife TGF-β uses a novel mode of receptor activation to phosphorylate SMAD1/5 and induce epithelial-to-mesenchymal transition | eLife](https://iiif.elifesciences.org/lax/31756%2Felife-31756-fig5-v2.tif/full/1500,/0/default.jpg)
TGF-β uses a novel mode of receptor activation to phosphorylate SMAD1/5 and induce epithelial-to-mesenchymal transition | eLife
An Integrated Expression Profiling Reveals Target Genes of TGF-β and TNF-α Possibly Mediated by MicroRNAs in Lung Cancer Cells | PLOS ONE
Binding Properties of the Transforming Growth Factor-β Coreceptor Betaglycan: Proposed Mechanism for Potentiation of Receptor Complex Assembly and Signaling | Biochemistry
![Analysis of pathways responsible for the expression of TGF-β target genes. | Download Scientific Diagram Analysis of pathways responsible for the expression of TGF-β target genes. | Download Scientific Diagram](https://www.researchgate.net/publication/279302719/figure/fig2/AS:688560906723331@1541177121525/Analysis-of-pathways-responsible-for-the-expression-of-TGF-b-target-genes.jpg)
Analysis of pathways responsible for the expression of TGF-β target genes. | Download Scientific Diagram
![MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling: Cell MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling: Cell](https://www.cell.com/cms/attachment/2021769033/2041633561/fx1.jpg)